Kran Suknuntha, Ph.D. - Publications

Affiliations: 
2013 Cellular & Molecular Pathology University of Wisconsin, Madison, Madison, WI 
Area:
Cell Biology, Medicine and Surgery

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Jung HS, Suknuntha K, Kim YH, Liu P, Dettle ST, Sedzro DM, Smith PR, Thomson JA, Ong IM, Slukvin II. SOX18-enforced expression diverts hemogenic endothelium-derived progenitors from T towards NK lymphoid pathways. Iscience. 26: 106621. PMID 37250328 DOI: 10.1016/j.isci.2023.106621  0.688
2022 Weinfurter JT, D'Souza SS, Matschke LM, Bennett S, Kelnhofer-Millevolte LE, Suknuntha K, Kumar A, Coonen J, Capitini CM, Hematti P, Golos TG, Slukvin II, Reynolds MR. Allogeneic MHC-matched T-cell receptor α/β-depleted bone marrow transplants in SHIV-infected, ART-suppressed Mauritian cynomolgus macaques. Scientific Reports. 12: 12345. PMID 35853970 DOI: 10.1038/s41598-022-16306-z  0.584
2021 Jung HS, Uenishi G, Park MA, Liu P, Suknuntha K, Raymond M, Choi YJ, Thomson JA, Ong IM, Slukvin II. SOX17 integrates HOXA and arterial programs in hemogenic endothelium to drive definitive lympho-myeloid hematopoiesis. Cell Reports. 34: 108758. PMID 33596423 DOI: 10.1016/j.celrep.2021.108758  0.628
2020 Suknuntha K, Choi YJ, Jung HS, Majumder A, Shah S, Slukvin I, Ranheim EA. Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition. Frontiers in Oncology. 10: 585151. PMID 33363015 DOI: 10.3389/fonc.2020.585151  0.548
2020 D'Souza SS, Bennett S, Kumar A, Kelnhofer LE, Weinfurter J, Suknuntha K, Coonen J, Mejia A, Simmons H, Golos T, Hematti P, Capitini CM, Reynolds MR, Slukvin II. Transplantation of TCRα/β-depleted allogeneic bone marrow in nonhuman primates. Experimental Hematology. PMID 33176119 DOI: 10.1016/j.exphem.2020.09.198  0.588
2020 Majumder A, Suknuntha K, Bennin D, Klemm L, Brok-Volchanskaya VS, Huttenlocher A, Slukvin I. Generation of Human Neutrophils from Induced Pluripotent Stem Cells in Chemically Defined Conditions Using Modified mRNA. Star Protocols. 1. PMID 33043305 DOI: 10.1016/j.xpro.2020.100075  0.624
2019 Brok-Volchanskaya VS, Bennin DA, Suknuntha K, Klemm LC, Huttenlocher A, Slukvin I. Effective and Rapid Generation of Functional Neutrophils from Induced Pluripotent Stem Cells Using ETV2-Modified mRNA. Stem Cell Reports. PMID 31708474 DOI: 10.1016/J.Stemcr.2019.10.007  0.681
2019 Mesquitta WT, Wandsnider M, Kang H, Thomson J, Moskvin O, Suknuntha K, Slukvin II. UM171 expands distinct types of myeloid and NK progenitors from human pluripotent stem cells. Scientific Reports. 9: 6622. PMID 31036928 DOI: 10.1038/S41598-019-43054-4  0.697
2019 Ospondpant D, Phuagkhaopong S, Suknuntha K, Sangpairoj K, Kasemsuk T, Srimaroeng C, Vivithanaporn P. Cadmium induces apoptotic program imbalance and cell cycle inhibitor expression in cultured human astrocytes. Environmental Toxicology and Pharmacology. 65: 53-59. PMID 30537571 DOI: 10.1016/J.Etap.2018.12.001  0.39
2018 Kumar A, Lee JH, Suknuntha K, D'Souza SS, Thakur AS, Slukvin II. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 30578305 DOI: 10.4049/Jimmunol.1801027  0.691
2018 Suknuntha K, Yubolphan R, Krueaprasertkul K, Srihirun S, Sibmooh N, Vivithanaporn P. Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells Asian Pacific Journal of Cancer Prevention : Apjcp. 19: 833-837. PMID 29582642 DOI: 10.22034/Apjcp.2018.19.3.833  0.305
2018 Suknuntha K, Tao L, Brok-Volchanskaya V, D'Souza SS, Kumar A, Slukvin I. Optimization of Synthetic mRNA for Highly Efficient Translation and its Application in the Generation of Endothelial and Hematopoietic Cells from Human and Primate Pluripotent Stem Cells. Stem Cell Reviews. PMID 29520567 DOI: 10.1007/S12015-018-9805-1  0.683
2018 Mesquitta W, Kang H, Wandsnider M, Brok-Volchanskaya V, Suknuntha K, Slukvin I. Pyrimido-Indole Derivative, UM171 Expands Distinct Types of Myeloid and Lymphoid Progenitors from Human Pluripotent Stem Cells Blood. 132: 3835-3835. DOI: 10.1182/Blood-2018-99-118303  0.733
2018 Mesquitta W, Kang H, Wandsnider M, Suknuntha K, Slukvin I. Pyrimido-Indole Derivative, UM171 Promotes Differentiation and Expansion of Myeloid Progenitors and NK Cells From Human Pluripotent Stem Cells Experimental Hematology. 64: S86-S87. DOI: 10.1016/J.Exphem.2018.06.096  0.731
2017 Tao L, Togarrati PP, Choi KD, Suknuntha K. StemRegenin 1 selectively promotes expansion of Multipotent Hematopoietic Progenitors derived from Human Embryonic Stem Cells. Journal of Stem Cells & Regenerative Medicine. 13: 75-79. PMID 29391752  0.551
2016 Suknuntha K, Thita T, Togarrati PP, Ratanachamnong P, Wongtrakoongate P, Srihirun S, Slukvin I, Hongeng S. Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines. International Journal of Hematology. PMID 27766528 DOI: 10.1007/S12185-016-2116-X  0.64
2016 Hafner AL, Contet J, Ravaud C, Yao X, Villageois P, Suknuntha K, Annab K, Peraldi P, Binetruy B, Slukvin II, Ladoux A, Dani C. Brown-like adipose progenitors derived from human induced pluripotent stem cells: Identification of critical pathways governing their adipogenic capacity. Scientific Reports. 6: 32490. PMID 27577850 DOI: 10.1038/Srep32490  0.687
2015 Suknuntha K, Ishii Y, Tao L, Hu K, McIntosh BE, Yang D, Swanson S, Stewart R, Wang JY, Thomson J, Slukvin I. Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells. Stem Cell Research. 15: 678-693. PMID 26561938 DOI: 10.1016/J.Scr.2015.10.015  0.716
2014 Suknuntha K, Ishii Y, Hu K, Brayan M, Yang DT, Swanson S, Stewart R, Wang JY, Thomson J, Slukvin I. Induced Pluripotent Stem Cell Model of Chronic Myeloid Leukemia Revealed Olfactomedin 4 As a Novel Survival Factor for Primitive Leukemia Cells Blood. 124: 397-397. DOI: 10.1182/Blood.V124.21.397.397  0.718
2013 Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, Whitaker JW, Tian S, Hawkins RD, Leung D, Yang H, Wang T, Lee AY, Swanson SA, Zhang J, ... ... Suknuntha K, et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell. 153: 1134-48. PMID 23664764 DOI: 10.1016/J.Cell.2013.04.022  0.666
2012 Choi KD, Vodyanik MA, Togarrati PP, Suknuntha K, Kumar A, Samarjeet F, Probasco MD, Tian S, Stewart R, Thomson JA, Slukvin II. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Reports. 2: 553-67. PMID 22981233 DOI: 10.1016/J.Celrep.2012.08.002  0.742
2012 Togarrati PP, Suknuntha K. Generation of mature hematopoietic cells from human pluripotent stem cells. International Journal of Hematology. 95: 617-23. PMID 22648826 DOI: 10.1007/S12185-012-1094-X  0.624
2011 Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, Stewart R, Thomson JA, Slukvin II. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 117: e109-19. PMID 21296996 DOI: 10.1182/Blood-2010-07-298331  0.722
2011 Suknuntha K, Ishii Y, Hu K, Wang JY, Slukvin I. Modeling CML Development and Drug Resistance Using iPSC Technology, Blood. 118: 3767-3767. DOI: 10.1182/Blood.V118.21.3767.3767  0.729
2011 Vodyanik M, Togarrati P, Suknuntha K, Choi K, Slukvin I. Identification of Distinct Pathways Involved in Regulation of Mesenchymoangioblasts and Hemangioblasts Development From Mesoderm Blood. 118: 1326-1326. DOI: 10.1182/Blood.V118.21.1326.1326  0.685
Show low-probability matches.